Δ9-THC increases endogenous AHA1 expression in rat cerebellum and may modulate CB1 receptor function during chronic use

Journal of Neurochemistry

Volumn 118, Issue 6, 2011, Pages 1101-1112

  Filipeanu, Catalin M ^a   Guidry, Jesse J ^a   Leonard, Stuart T ^a   Winsauer, Peter J ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

9 THC; AHA1; CB1R; cerebellum; molecular chaperones; proteomic analysis

Indexed keywords

AHA1 PROTEIN; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CHAPERONE; CYCLIC AMP; DJ 1 PROTEIN; HEAT SHOCK PROTEIN 90; MITOCHONDRIAL PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NM23B PROTEIN; PYRUVATE CARBOXYLASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; TETRAHYDROCANNABINOLIC ACID; UNCLASSIFIED DRUG;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANNABIS ADDICTION; CELL MEMBRANE; CELL SURFACE; CEREBELLUM; CONTROLLED STUDY; EMBRYO; ENZYME PHOSPHORYLATION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEOMICS; RAT;

ANIMALS; BLOTTING, WESTERN; CELL LINE; CELL MEMBRANE; CEREBELLUM; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLIC AMP; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; IMMUNOPRECIPITATION; MARIJUANA ABUSE; MASS SPECTROMETRY; MICROSCOPY, FLUORESCENCE; MOLECULAR CHAPERONES; OVARIECTOMY; PROTEOMICS; RATS; RATS, LONG-EVANS; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; RECEPTORS, CELL SURFACE; TETRAHYDROCANNABINOL; TRANSFECTION;

CANNABIS SATIVA; RATTUS;

EID: 80052387561     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2011.07391.x     Document Type: Article

References (58)

1. Alban A., David S. O., Bjorkesten L., Andersson C., Sloge E., Lewis S., and, Currie I., (2003) A novel experimental design for comparative two-dimensional gel analysis: two-dimensional difference gel electrophoresis incorporating a pooled internal standard. Proteomics 3, 36-44. (Pubitemid 36151066)
2. Bosier B., Muccioli G. G., Hermans E., and, Lambert D. M., (2010) Functionally selective cannabinoid receptor signalling: therapeutic implications and opportunities. Biochem. Pharmacol. 80, 1-12.
3. Bosnar M. H., Bago R., and, CetkoviÄ H., (2009) Subcellular localization of Nm23/NDPK A and B isoforms: a reflection of their biological function? Mol. Cell. Biochem. 329, 63-71.
4. Cabral G. A., Raborn E. S., Griffin L., Dennis J., and, Marciano-Cabral F., (2008) CB2 receptors in the brain: role in central immune function. Br. J. Pharmacol. 153, 240-251.
5. Childers S. R., (2006) Activation of G-proteins in brain by endogenous and exogenous cannabinoids. AAPS J. 8, E112-E117.
6. Colombo G., Rusconi F., Rubino T., Cattaneo A., Martegani E., Parolaro D., Bachi A., and, Zippel R., (2009) Transcriptomic and proteomic analyses of mouse cerebellum reveals alterations in RasGRF1 expression following in vivo chronic treatment with delta 9-tetrahydrocannabinol. J. Mol. Neurosci. 37, 111-122.
7. Cooray S. N., Chan L., Webb T. R., Metherell L., and, Clark A. J., (2009) Accessory proteins are vital for the functional expression of certain G protein-coupled receptors. Mol. Cell. Endocrinol. 300, 17-24.
8. da Costa C. A., (2007) DJ-1: a newcomer in Parkinson's disease pathology. Curr. Mol. Med. 7, 650-657.
9. Cudaback E., Marrs W., Moeller T., and, Stella N., (2010) The expression level of CB1 and CB2 receptors determines their efficacy at inducing apoptosis in astrocytomas. PLoS ONE 5, e8702.
10. Daniel J. M., Winsauer P. J., Brauner I. N., and, Moerschbaecher J. M., (2002) Estrogen improves response accuracy and attenuates the disruptive effects of delta9-THC in ovariectomized rats responding under a multiple schedule of repeated acquisition and performance. Behav. Neurosci. 116, 989-998. (Pubitemid 35429634)
11. DeWire S. M., Ahn S., Lefkowitz R. J., and, Shenoy S. K., (2007) Beta-arrestins and cell signaling. Annu. Rev. Physiol. 69, 483-510.
12. Dong C., Filipeanu C. M., Duvernay M. T., and, Wu G., (2007) Regulation of G protein-coupled receptor export trafficking. Biochim. Biophys. Acta 1768, 853-870. (Pubitemid 46452538)
13. Dunham J. H., and, Hall R. A., (2009) Enhancement of the surface expression of G protein-coupled receptors. Trends Biotechnol. 27, 541-545.
14. Duvernay M. T., Filipeanu C. M., and, Wu G., (2005) The regulatory mechanisms of export trafficking of G protein-coupled receptors. Cell. Signal. 17, 1457-1465. (Pubitemid 41253985)
15. Eloqayli H., Dahl C. B., Götestam K. G., UnsgÃrd G., and, Sonnewald U., (2004) Changes of glial-neuronal interaction and metabolism after a subconvulsive dose of pentylenetetrazole. Neurochem. Int. 45, 739-745. (Pubitemid 38844896)
16. 2+]i increases partly sensitive to capacitative store refilling. Eur. J. Pharmacol. 336, R1-R3. (Pubitemid 27462769)
17. Filipeanu C. M., Zhou F., Claycomb W. C., and, Wu G., (2004) Regulation of the cell surface expression and function of angiotensin II type 1 receptor by Rab1-mediated endoplasmic reticulum-to-Golgi transport in cardiac myocytes. J. Biol. Chem. 279, 41077-41084. (Pubitemid 39287709)
18. Filipeanu C. M., Zhou F., Lam M. L., Kerut K. E., Claycomb W. C., and, Wu G., (2006) Enhancement of the recycling and activation of beta-adrenergic receptor by Rab4 GTPase in cardiac myocytes. J. Biol. Chem. 281, 11097-11103. (Pubitemid 43855534)
19. Filipeanu C. M., de Vries R., Danser A. H., and, Kapusta D. R., (2011) Modulation of α(2C) adrenergic receptor temperature-sensitive trafficking by HSP90. Biochim. Biophys. Acta 1813, 346-357.
20. Gachet Y., Tournier S., Lee M., Lazaris-Karatzas A., Poulton T., and, Bommer U. A., (1999) The growth-related, translationally controlled protein P23 has properties of a tubulin binding protein and associates transiently with microtubules during the cell cycle. J. Cell Sci. 112, 1257-1271. (Pubitemid 29218914)
21. Ghandour M. S., Parkkila A. K., Parkkila S., Waheed A., and, Sly W. S., (2000) Mitochondrial carbonic anhydrase in the nervous system: expression in neuronal and glial cells. J. Neurochem. 75, 2212-2220.
22. Godlewski G., Offertáler L., Wagner J. A., and, Kunos G., (2009) Receptors for acylethanolamides-GPR55 and GPR119. Prostaglandins Other Lipid Mediat. 89, 105-111.
23. Gomes I., Grushko J. S., Golebiewska U., Hoogendoorn S., Gupta A., Heimann A. S., Ferro E. S., Scarlata S., Fricker L. D., and, Devi L. A., (2009) Novel endogenous peptide agonists of cannabinoid receptors. FASEB J. 23, 3020-3029.
24. He F., Qiao Z. H., Cai J., Pierce W., He D. C., and, Song Z. H., (2007) Involvement of the 90-kDa heat shock protein (Hsp-90) in CB2 cannabinoid receptor-mediated cell migration: a new role of Hsp-90 in migration signaling of a G protein-coupled receptor. Mol. Pharmacol. 72, 1289-1300. (Pubitemid 350012602)
25. Heimann A. S., Gomes I., Dale C. S., et al. (2007) Hemopressin is an inverse agonist of CB1 cannabinoid receptors. Proc. Natl. Acad. Sci. USA 104, 20588-20593.
26. Herkenham M., Lynn A. B., Little M. D., Johnson M. R., Melvin L. S., de Costa B. R., and, Rice K. C., (1990) Cannabinoid receptor localization in brain. Proc. Natl. Acad. Sci. USA 87, 1932-1936.
27. Herkenham M., Lynn A. B., Johnson M. R., Melvin L. S., de Costa B. R., and, Rice K. C., (1991) Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci. 11, 563-583.
28. Hirst J., (2009) Towards the molecular mechanism of respiratory complex I. Biochem. J. 425, 327-339.
29. Holmes J. L., Sharp S. Y., Hobbs S., and, Workman P., (2008) Silencing of HSP90 cochaperone AHA1 expression decreases client protein activation and increases cellular sensitivity to the HSP90 inhibitor 17-allylamino-17- demethoxygeldanamycin. Cancer Res. 68, 1188-1197.
30. Jitrapakdee S., St Maurice M., Rayment I., Cleland W. W., Wallace J. C., and, Attwood P. V., (2008) Structure, mechanism and regulation of pyruvate carboxylase. Biochem. J. 413, 369-387.
31. Kim S. H., Cairns N., Fountoulakisc M., and, Lubec G., (2001) Decreased brain histamine-releasing factor protein in patients with Down syndrome and Alzheimer's disease. Neurosci. Lett. 300, 41-44.
32. Leterrier C., Bonnard D., Carrel D., Rossier J., and, Lenkei Z., (2004) Constitutive endocytic cycle of the CB1 cannabinoid receptor. J. Biol. Chem. 279, 36013-36021. (Pubitemid 39100609)
33. Lotz G. P., Lin H., Harst A., and, Obermann W. M., (2003) Aha1 binds to the middle domain of Hsp90, contributes to client protein activation, and stimulates the ATPase activity of the molecular chaperone. J. Biol. Chem. 278, 17228-17335.
34. Luo S., Zhang B., Dong X. P., et al. (2008) HSP90 beta regulates rapsyn turnover and subsequent AChR cluster formation and maintenance. Neuron 60, 97-110.
35. Mackie K., (2008) Cannabinoid receptors: where they are and what they do. J. Neuroendocrinol. 20, 10-14.
36. Marella M., Seo B. B., Yagi T., and, Matsuno-Yagi A., (2009) Parkinson's disease and mitochondrial complex I: a perspective on the Ndi1 therapy. J. Bioenerg. Biomembr. 41, 493-497.
37. Marshall J. C., Collins J., Marino N., and, Steeg P., (2010) The Nm23-H1 metastasis suppressor as a translational target. Eur. J. Cancer 46, 1278-1282.
38. Matsumoto A., (1991) Synaptogenic action of sex steroids in developing and adult neuroendocrine brain. Psychoneuroendocrinology 16, 25-40.
39. Mechoulam R., (1986) The pharmacology of cannabis sativa, in Cannabinoids as Therapeutic Agents (, Mechoulam R., ed.), pp. 1-19. CR, Boca Raton, FL.
40. Molina P. E., Winsauer P., Zhang P., et al. (2011) Cannabinoid administration attenuates the progression of simian immunodeficiency virus. AIDS Res. Hum. Retroviruses 27, 585-592.
41. Mollapour M., Tsutsumi S., Truman A. W., et al. (2011) Threonine 22 phosphorylation attenuates Hsp90 interaction with cochaperones and affects its chaperone activity. Mol. Cell 41, 672-681.
42. National Research Council (1996) Guide for the Care and Use of Laboratory. National Academy Press, Washington, DC.
43. Oz M,. (2006) Receptor-independent actions of cannabinoids on cell membranes: focus on endocannabinoids. Pharmacol. Ther. 111, 114-144 (Pubitemid 43786201)
44. Pearl L. H., Prodromou C., and, Workman P., (2008) The Hsp90 molecular chaperone: an open and shut case for treatment. Biochem. J. 410, 439-453. (Pubitemid 351429015)
45. Pope H. G., Jr, Jacobs A., Mialet J. P., Yurgelun-Todd D., and, Gruber S., (1997) Evidence for a sex-specific residual effect of cannabis on visuospatial memory. Psychother. Psychosom. 66, 179-184. (Pubitemid 27331200)
46. Ramos R. R., Swanson A. J., and, Bass J., (2007) Calreticulin and Hsp90 stabilize the human insulin receptor and promote its mobility in the endoplasmic reticulum. Proc. Natl. Acad. Sci. USA 104, 10470-10475. (Pubitemid 47185689)
47. Reggio P. H., (2010) Endocannabinoid binding to the cannabinoid receptors: what is known and what remains unknown. Curr. Med. Chem. 17, 1468-1486.
48. Ritossa F., (1962) A new puffing pattern induced by temperature shock and DNP in Drosophila. Experientia 18, 571-573.
49. Rozenfeld R., (2011) Type I cannabinoid receptor trafficking: all roads lead to lysosome. Traffic 12, 12-18.
50. Rozenfeld R., and, Devi L. A., (2008) Regulation of CB1 cannabinoid receptor trafficking by the adaptor protein AP-3. FASEB J. 22, 2311-2322. (Pubitemid 351948649)
51. Seamon M. J., Fass J. A., Maniscalco-Feichtl M., and, Abu-Shraie N. A., (2007) Medical marijuana and the developing role of the pharmacist. Am. J. Health Syst. Pharm. 64, 1037-1044. (Pubitemid 46801535)
52. Taherian A., Krone P. H., and, Ovsenek N., (2008) A comparison of Hsp90alpha and Hsp90beta interactions with cochaperones and substrates. Biochem. Cell Biol. 86, 37-45. (Pubitemid 351235984)
53. The UniProt Consortium (2011) Ongoing and future developments at the Universal Protein Resource. Nucleic Acids Res. 39, D214-D219.
54. Thompson D. M., and, Moerschbaecher J. M., (1978) Operant methodology in the study of learning. Environ. Health Perspect. 26, 77-87. (Pubitemid 9076097)
55. Turu G., and, Hunyady L., (2010) Signal transduction of the CB1 cannabinoid receptor. J. Mol. Endocrinol. 44, 75-85.
56. 2+-pump SERCA2b interacts with G protein-coupled receptors and enhances their expression at the cell surface. J. Mol. Biol. 371, 622-638. (Pubitemid 47087814)
57. Wang X., Venable J., LaPointe P., et al. (2006) Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. Cell 127, 803-815. (Pubitemid 44716255)
58. Winsauer P. J., Daniel J. M., Filipeanu C. M., Leonard S. T., Hulst J. L., Rodgers S. P., Lassen-Greene C. L., and, Sutton J. L., (2011) Long-term behavioral and pharmacodynamic effects of delta-9-tetrahydrocannabinol in female rats depend on ovarian hormone status. Addict. Biol. 16, 64-81.